In this exploratory study, the expression of glycolytic and ketolytic genes in the context of MYCN oncogene amplification, tumour staging 1–4 and Kaplan–Meier survivability was investigated using the R2: Genomics analysis and visualisation platform (http://r2.amc.nl), database. This evidence concerns the gene MYCN and neoplasm.